1 unchanged sentence
Description of Exhibit
−Removed: Addendum to the employment agreement between William Febbo and the Company dated September 24, 2020
+Added: OptimizeRx 2021 Equity Incentive Plan.
+Added: Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 25, 2021.
+Added: Form of Stock Option Award for grants under the OptimizeRx Corporation 2021 Equity Incentive Plan.
+Added: Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on August 25, 2021.
+Added: Form of Performance Stock Option Award for grants under the OptimizeRx Corporation 2021 Equity Incentive Plan.
+Added: Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on August 25, 2021.
+Added: Form of Restricted Stock Unit Award for grants under the OptimizeRx Corporation 2021 Equity Incentive Plan.
+Added: Incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on August 25, 2021.
+Added: Form of Performance Restricted Stock Unit Award for grants under the OptimizeRx Corporation 2021.
+Added: Incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed on August 25, 2021.
+Added: Offer Letter by and between the Company and Edward Stelmakh.
+Added: Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 30, 2021.
Certification of Chief Executive Officer pursuant to 18 U.S.C.
9 unchanged sentences
Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document.
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
+Added: * Exhibits have been omitted to
+Added: Item 601(a)(5) of Regulation S-K.
+Added: The Company agrees to furnish supplementally a copy of any omitted exhibit to the SEC upon request.
** Provided herewith
−Removed: In accordance with the requirements of the Securities and Exchange
−Removed: Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
+Added: accordance with the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed
+Added: on its behalf by the undersigned, thereunto duly authorized.
OptimizeRx Corporation
−Removed: August 4, 2021
−Removed: /s/ William J.
−Removed: Chief Executive Officer,
−Removed: Principal Executive Officer, and Director
+Added: November 9, 2021
+Added: Chief Executive Officer and
+Added: Principal Executive Officer
OptimizeRx Corporation
−Removed: August 4, 2021
−Removed: /s/ Douglas P.
+Added: November 9, 2021
+Added: Edward Stelmakh
Chief Financial Officer,
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.